Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparing frequencies of adolescent suicide attempters pre- and during COVID-19 pandemic school terms

  • Gracia Liso, Rebeca|||0000-0002-0713-447X
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Pujals-Altés, Elena
  • Puntí Vidal, Joaquim|||0000-0001-6572-3398
  • Llorens, Marta|||0000-0001-8532-0115
  • Pamias, Montserrat|||0000-0003-1114-5419
  • Jiménez, Marc Fradera
  • Aguirrezabala, Itziar Montalvo
  • Palao, Diego|||0000-0002-3323-6568
The COVID-19 pandemic had and still have a major impact on adolescent mental health and consequently on suicidal behavior. However, few studies have investigated whether the pandemic has changed the patterns and the triggers of suicidality peaks in adolescents, e.g., seasonal patterns or family conflicts. We hypothesized that the pandemic modified suicidality rates: an increment of suicide attempts would be observed in the first semester of the academic year during COVID-19 pandemic compared to the same period of previous academic year; and the precipitating factors would be more related to social stressors during the pandemic school year. A retrospective cross-sectional study was conducted to assess the precipitating factors, also including school-related factors and cognitive skills, of adolescent suicide attempters occurred in the first and second semesters of the year before the pandemic lockdown (study periods 1 and 2) and the year after (study periods 3 and 4). The sample consisted of 85 adolescents aged between 12 and 17 recruited consecutively from March 2019 to March 2021 at emergency ward because of suicide attempt. Forty-eight adolescents (55.3% of the sample) were attended before the lockdown (pre-pandemic group) and 38 (44.7%) the year after. The results showed a higher proportion of female suicide attempters in period 4 (Sept 2020-Feb 2021) respect to period 3 (Mar 2020-Aug 2020), i.e., pandemic semesters compared with the increment observed between period 2 and 1 (prepandemic semesters; Fisher's exact test = 4.73; p = 0.026). The multinomial regression models showed a significant effect in the frequency of adolescents who attempted suicide (ratio χ = 15.19, p = 0.019), accounted by the differences between period 4 (Sept 2020-Feb 2021) and period 1 (Mar 2019-Aug 2019), with depressive symptoms being a significant contributing factor (Exp(b) = 0.93; p = 0.04). Additionally, social triggers and age were found to be significant risk factors for suicide attempts in the first semester of the pandemic academic year (period 4) compared to the same semester of the pre-pandemic year (period 2; Exp(b) = 0.16, p = 0.01, and Exp(b) = 1.88, p = 0.006, respectively). During the pandemic, the decrement between first and second semester of the number of females attempting suicide was more pronounced than in the prepandemic school year -though this findings lacked statistical power due to very limited sample size-. Change in the frequency of adolescent attempting suicide in the different school periods was associated with greater severity of depressive symptoms. Social relations in back-to-school after the lockdown were also associated with the number of adolescents attempting suicide.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder

  • Vicent Gil, Muriel|||0000-0001-7534-5095
  • Trujols, Joan|||0000-0003-0396-7105
  • Sagués Junqueras, Teresa
  • Serra Blasco, Maria|||0000-0001-5793-9906
  • Navarra-Ventura, Guillem|||0000-0001-9839-7357
  • Mantellini, Cecilia Lucía
  • Crivillés, Sara|||0000-0003-2787-4069
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Cardoner, Narcís|||0000-0001-9633-0888
Background: Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, has demonstrated efficacy in improving affective symptoms of Major Depressive Disorder (MDD); however, its effects on associated cognitive and functional difficulties remain underexplored. This study seeks to assess the antidepressant effects of desvenlafaxine in patients with SSRI-resistant MDD, its impact on both objective and subjective cognitive performance, where cognitive improvements occur independently of clinical recovery or not, and its influence on psychosocial functioning. Methods: An observational case-control prospective study with 66 participants was conducted, including 26 patients with a current MDD episode, with an inadequate SSRI response, and with the prescription of desvenlafaxine as the next antidepressant therapeutic option, and 40 healthy controls. Sociodemographic, clinical, cognitive, and functional assessments were conducted both before and after a 12-week treatment period. Changes were analyzed using two tailed paired-samples t-tests, with Cohen's d for effect sizes. Cognitive improvements were compared between the patients who achieved remission and those who did not. Results: Patients showed significant improvements in depressive and anxiety symptoms, attention/working memory and processing speed, self-perceived cognitive difficulties and psychosocial functioning. Highlighting the fact these cognitive enhancements occurred independently of patients' clinical improvement. Conclusions: The findings of this study focus on the therapeutic potential of desvenlafaxine, demonstrating its efficacy not only in ameliorating clinical and functional symptoms but also in addressing specific cognitive impairments in patients with depression. Further research is needed to elucidate the mechanisms underlying desvenlafaxine's effects and optimize treatment strategies for individuals with MDD. Trial registration number: NCT03432221 (clinical.trials.gov). Registration date: 08-01-2018.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluating the efficacy of radically open dialectical behavior therapy (RO-DBT) in patients with anorexia nervosa, study protocol for a randomized controlled clinical trial

  • Avila-Parcet, Aina|||0000-0002-7355-0420
  • Martin Blanco, Ana|||0000-0002-3917-0854
  • Gawron, Leonor Patricia|||0000-0003-0165-7349
  • Cano, Marta|||0000-0003-0675-9483
  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Carceller-Sindreu, Mar|||0000-0001-7504-3935
  • Soler, Joaquim|||0000-0001-8077-3641
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Faustino, Gloria
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Carmona i Farrés, Cristina|||0000-0002-7028-3697
Anorexia nervosa (AN) is a severe and disabling disorder, with relapse rates as high as 50% after the first episode, posing a significant challenge for clinicians. Most therapies excessively focus on nourishment, resulting in temporary weight restoration but with no improvements in general well-being and quality of life. Radically Open Dialectical Behavior Therapy (RO-DBT) is a transdiagnostic treatment designed to address overcontrol, a key aspect in the functioning of patients with AN. To date, no clinical trial (CT) has shown its efficacy in these patients or evaluated its neurobiological mechanism of action. A randomized CT in weight restored adult AN patients will be conducted, with one group receiving treatment as usual (TAU) and the other TAU plus RO-DBT, with the main outcome being quality of life. Secondary variables will include eating disorders (EDs) symptoms, overcontrol characteristics, autistic traits, and neuroimaging changes. The results will address a gap in knowledge regarding AN treatment, with the expectation that patients receiving TAU with RO-DBT will exhibit improved quality of life and experience fewer relapses at the one-year follow-up. This is the first study examining neuroimaging changes in RO-DBT to better understand its underlying mechanisms.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders

  • Segal, Ashlea|||0000-0002-7451-6195
  • Parkes, Linden|||0000-0002-9329-7207
  • Aquino, Kevin
  • Kia, Seyed Mostafa
  • Wolfers, Thomas
  • Franke, Barbara|||0000-0003-4375-6572
  • Hoogman, Martine|||0000-0002-1261-7628
  • Beckmann, Christian F.
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Zalesky, Andrew|||0000-0003-2298-9908
  • Harrison, Ben J.
  • Davey, Christopher|||0000-0003-1431-3852
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Tiego, Jeggan|||0000-0001-7835-6398
  • Yücel, Murat|||0000-0002-4705-452X
  • Braganza, Leah
  • Suo, Chao
  • Berk, Michael
  • Cotton, Sue
  • Bellgrove, Mark A.|||0000-0003-0186-8349
  • Marquand, Andre F.|||0000-0001-5903-203X
  • Fornito, Alex|||0000-0003-0866-3477
The substantial individual heterogeneity that characterizes people with mental illness is often ignored by classical case-control research, which relies on group mean comparisons. Here we present a comprehensive, multiscale characterization of the heterogeneity of gray matter volume (GMV) differences in 1,294 cases diagnosed with one of six conditions (attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, depression, obsessive-compulsive disorder and schizophrenia) and 1,465 matched controls. Normative models indicated that person-specific deviations from population expectations for regional GMV were highly heterogeneous, affecting the same area in <7% of people with the same diagnosis. However, these deviations were embedded within common functional circuits and networks in up to 56% of cases. The salience-ventral attention system was implicated transdiagnostically, with other systems selectively involved in depression, bipolar disorder, schizophrenia and attention-deficit/hyperactivity disorder. Phenotypic differences between cases assigned the same diagnosis may thus arise from the heterogeneous localization of specific regional deviations, whereas phenotypic similarities may be attributable to the dysfunction of common functional circuits and networks. A new brain mapping approach tailored to individual people reveals that volume changes in psychiatric illness occur in highly variable locations across individuals, but that these differences often aggregate within common brain systems.